SG11202102527SA - Oral composition containing reduced coenzyme q10, method for producing same, method for preventing discoloration and discoloration preventing agent - Google Patents
Oral composition containing reduced coenzyme q10, method for producing same, method for preventing discoloration and discoloration preventing agentInfo
- Publication number
- SG11202102527SA SG11202102527SA SG11202102527SA SG11202102527SA SG11202102527SA SG 11202102527S A SG11202102527S A SG 11202102527SA SG 11202102527S A SG11202102527S A SG 11202102527SA SG 11202102527S A SG11202102527S A SG 11202102527SA SG 11202102527S A SG11202102527S A SG 11202102527SA
- Authority
- SG
- Singapore
- Prior art keywords
- discoloration
- preventing
- composition containing
- oral composition
- producing same
- Prior art date
Links
- 238000002845 discoloration Methods 0.000 title 2
- 239000003795 chemical substances by application Substances 0.000 title 1
- 238000004519 manufacturing process Methods 0.000 title 1
- 238000000034 method Methods 0.000 title 1
- QNTNKSLOFHEFPK-UPTCCGCDSA-N ubiquinol-10 Chemical compound COC1=C(O)C(C)=C(C\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CCC=C(C)C)C(O)=C1OC QNTNKSLOFHEFPK-UPTCCGCDSA-N 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23B—PRESERVATION OF FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES; CHEMICAL RIPENING OF FRUIT OR VEGETABLES
- A23B2/00—Preservation of foods or foodstuffs, in general
- A23B2/70—Preservation of foods or foodstuffs, in general by treatment with chemicals
- A23B2/725—Preservation of foods or foodstuffs, in general by treatment with chemicals in the form of liquids or solids
- A23B2/729—Organic compounds; Microorganisms; Enzymes
- A23B2/762—Organic compounds containing nitrogen
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23B—PRESERVATION OF FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES; CHEMICAL RIPENING OF FRUIT OR VEGETABLES
- A23B2/00—Preservation of foods or foodstuffs, in general
- A23B2/70—Preservation of foods or foodstuffs, in general by treatment with chemicals
- A23B2/725—Preservation of foods or foodstuffs, in general by treatment with chemicals in the form of liquids or solids
- A23B2/729—Organic compounds; Microorganisms; Enzymes
- A23B2/771—Organic compounds containing hetero rings
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/12—Ketones
- A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
- A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/02—Antioxidant
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/04—Colour
- A23V2200/048—Preventing colour changes
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2250/00—Food ingredients
- A23V2250/02—Acid
- A23V2250/06—Amino acid
- A23V2250/0646—Theanine
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2250/00—Food ingredients
- A23V2250/30—Other Organic compounds
- A23V2250/314—Ubiquinone, coenzyme Qn
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nutrition Science (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Polymers & Plastics (AREA)
- Food Science & Technology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Physiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Mycology (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Obesity (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2018202060 | 2018-10-26 | ||
PCT/JP2019/040584 WO2020085155A1 (en) | 2018-10-26 | 2019-10-16 | Oral composition containing reduced coenzyme q10, method for producing same, method for preventing discoloration and discoloration preventing agent |
Publications (1)
Publication Number | Publication Date |
---|---|
SG11202102527SA true SG11202102527SA (en) | 2021-05-28 |
Family
ID=70332011
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SG11202102527SA SG11202102527SA (en) | 2018-10-26 | 2019-10-16 | Oral composition containing reduced coenzyme q10, method for producing same, method for preventing discoloration and discoloration preventing agent |
Country Status (10)
Country | Link |
---|---|
US (1) | US20210353557A1 (en) |
JP (1) | JP7350770B2 (en) |
KR (1) | KR20210086658A (en) |
CN (1) | CN112888321A (en) |
AU (1) | AU2019367475A1 (en) |
CA (1) | CA3117475A1 (en) |
MY (1) | MY205158A (en) |
SG (1) | SG11202102527SA (en) |
TW (1) | TWI834743B (en) |
WO (1) | WO2020085155A1 (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPWO2023120555A1 (en) * | 2021-12-24 | 2023-06-29 |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH036408A (en) | 1989-06-02 | 1991-01-11 | Rikagaku Kenkyusho | Laser shape measurement device for underwater objects |
TW200302056A (en) * | 2002-01-18 | 2003-08-01 | Kaneka Corp | Method for stabilizing reduced coenzyme Q10 and composition therefor |
JP5683768B2 (en) * | 2005-09-09 | 2015-03-11 | サントリーホールディングス株式会社 | Composition containing coenzyme Q10 |
US8642030B2 (en) * | 2006-08-25 | 2014-02-04 | Epc Europe Gmbh | Compositions containing coenzyme Q-10 and dihydrolipoic acid |
JP2010030901A (en) * | 2006-11-17 | 2010-02-12 | Kaneka Corp | Agent for alleviating or preventing stress symptom |
WO2010012751A2 (en) * | 2008-07-28 | 2010-02-04 | Omnica Gmbh | Sesame seed derived pigments |
JP2016140351A (en) * | 2015-01-30 | 2016-08-08 | ペトロユーロアジア株式会社 | Foods and drinks in which oxidation of reduction type coenzyme q10 is prevented |
-
2019
- 2019-10-16 WO PCT/JP2019/040584 patent/WO2020085155A1/en active Application Filing
- 2019-10-16 US US17/287,317 patent/US20210353557A1/en not_active Abandoned
- 2019-10-16 CN CN201980067533.2A patent/CN112888321A/en active Pending
- 2019-10-16 KR KR1020217015361A patent/KR20210086658A/en active Pending
- 2019-10-16 SG SG11202102527SA patent/SG11202102527SA/en unknown
- 2019-10-16 CA CA3117475A patent/CA3117475A1/en active Pending
- 2019-10-16 AU AU2019367475A patent/AU2019367475A1/en not_active Abandoned
- 2019-10-16 JP JP2020553212A patent/JP7350770B2/en active Active
- 2019-10-16 MY MYPI2021002166A patent/MY205158A/en unknown
- 2019-10-23 TW TW108138143A patent/TWI834743B/en active
Also Published As
Publication number | Publication date |
---|---|
WO2020085155A1 (en) | 2020-04-30 |
AU2019367475A1 (en) | 2021-05-06 |
JPWO2020085155A1 (en) | 2021-09-16 |
JP7350770B2 (en) | 2023-09-26 |
MY205158A (en) | 2024-10-04 |
US20210353557A1 (en) | 2021-11-18 |
KR20210086658A (en) | 2021-07-08 |
TW202029889A (en) | 2020-08-16 |
CN112888321A (en) | 2021-06-01 |
TWI834743B (en) | 2024-03-11 |
CA3117475A1 (en) | 2020-04-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL285302A (en) | Compounds, compositions and methods | |
PT3456717T (en) | Tablets containing 4,6-diamino-quinoline-3-carbonitrile derivatives as cancer osaka thyroid (cot) modulators for treating cancer | |
EP3446683A4 (en) | Coenzyme q10 solubilizing composition and method for preparing same | |
GB201910389D0 (en) | Novel compounds, methods for their manufacture, and uses thereof | |
GB2572610B (en) | Composition, methods for its production, and its use | |
GB201903787D0 (en) | Microcapsules containing curcumin, and methods for the production thereof | |
SG10202000426WA (en) | Polysiloxazane Compound, Method for Producing the Same, and Composition Containing the Same and Cured Product Thereof | |
IL286733A (en) | Compound, method and pharmaceutical composition for dux4 expression adjustment | |
EP3864969A4 (en) | Health product composition for supplementing deficiency, preparation method therefor and application thereof | |
IL287120A (en) | Compounds, compositions and methods | |
EP4030970A4 (en) | Breathable crib | |
GEP20186884B (en) | Slow-release solid oral compositions | |
SG11202102527SA (en) | Oral composition containing reduced coenzyme q10, method for producing same, method for preventing discoloration and discoloration preventing agent | |
HK1248121A1 (en) | Composition for oral cavity | |
ZA201803250B (en) | New 5-azido-5-deoxy-2 :3-isopropylidene-d-arabinose compounds; their method of manufacture and their use for the synthesis of ara-n3, kdo-n3 and 4ekdo-n3 | |
EP3480197C0 (en) | Pyrroloquinone quinone monosodium, method for manufacturing same, and composition including same | |
IL276732A (en) | Granular composition, production method for granular composition, and dissolution property improvement method for granular composition | |
PL3315120T3 (en) | Oral composition for tooth whitening | |
HUE040253T2 (en) | Pharmaceutical composition containing rifaximin alpha&delta | |
SG11202003286YA (en) | Cool-sensation imparter composition containing 2,2,6-trimethylcyclohexanecarboxylic acid derivative | |
SG11201913449YA (en) | Composition containing an oxidizing agent and method for using the same | |
EP3466400A4 (en) | Composition for oral cavity | |
EP4082514A4 (en) | Paste-like composition for dental use, and method for producing the same | |
IL274529A (en) | Compounds, compositions, and methods for treating and/or preventing periodontal disease | |
EP3241564A4 (en) | Composition for forming complex, complex formed therefrom, and composition for oral ingestion, containing same |